Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumours

✍ Scribed by Strumberg, D; Schultheis, B; Adamietz, I A; Christensen, O; Buechert, M; Kraetzschmar, J; Rajagopalan, P; Ludwig, M; Frost, A; Steinbild, S

• Book ID: 109999819
• Publisher: Nature Publishing Group
• Year: 2008
• Tongue: English
• Weight: 173 KB
• Volume: 99
• Category: Article
• ISSN: 0007-0920
• DOI: 10.1038/sj.bjc.6604724